Skip to content

Investigation of Muscle Oxygenation in Patients With Rheumatoid Arthritis

Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06769386
Enrollment
68
Registered
2025-01-10
Start date
2025-01-25
Completion date
2027-01-25
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

exercise capacity, muscle oxygenation, rheumatoid arthritis

Brief summary

The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.

Detailed description

Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease of unknown etiology with symmetric erosive synovitis and multisystem involvement. The disease causes significant long-term morbidity, reduced functional capacity, and increased mortality rates. Patients with rheumatoid arthritis avoid physical activity due to pain and fatigue. Despite the advances in pharmacological treatments in recent years, functional losses due to rheumatic diseases the resulting deterioration in quality of life, and loss of work continue. Physical inactivity is known to have detrimental effects on the cardiovascular and pulmonary systems by reducing muscle strength and aerobic capacity. The physiological reasons underlying skeletal muscle oxygenation that may cause muscle dysfunction in rheumatoid arthritis have not been investigated. In these patients, decreased arterial oxygen may reduce exercise capacity and cause muscle deoxygenation. In rheumatoid arthritis patients, decreases in respiratory muscle strength, lung volumes, oxygen consumption, and six minute walk test distance cause cardiopulmonary deconditioning. Decreased exercise capacity increases the risk of cardiovascular disease and causes mortality in patients with RA. This study aimed to, the effects of respiratory muscle strength, respiratory muscle endurance, upper and lower extremity muscle oxygenation, and upper and lower extremity exercise capacity in patients with stable disease activity.

Interventions

None listed

Sponsors

Kirsehir Ahi Evran Universitesi
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Rheumatoid Arthritis Group Inclusion Criteria: * Patients diagnosed with rheumatoid arthritis, * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study.

Exclusion criteria

* Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions, * Participated in a planned exercise program in the last three months, * Cognitive impairment that will cause difficulty in understanding and following exercise test instructions, * Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study. Control Group Inclusion Criteria: * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of respiratory muscle strengthFirst dayAn electronic mouth pressure measuring device that complies with American Thoracic Society and European Respiratory Society criteria will be used to assess respiratory muscle strength.
Evaluation of respiratory muscle enduranceFirst dayThe incremental threshold workload test will be used to assess respiratory muscle endurance.The PowerBreathe Wellness® (HaB International Ltd. Southam, United Kingdom) inspiratory muscle training device will be used in the incremental threshold load test.
Evaluation of Deltoid and Quadriceps Femoris Muscle OxygenationFirst and second dayMuscle oxygen level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.
Evaluation of Deltoid and Quadriceps Femoris Muscle Total Hemoglobin LevelFirst and second dayTotal hemoglobin level of quadriceps femoris and deltoid muscles will be measured using Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA) before, during and after the six-minute walk test and six-minute peg-board and ring test.

Secondary

MeasureTime frameDescription
Evaluation of submaximal exercise capacityFirst day and second dayThe six-minute walk test will be performed according to American Thoracic Society criteria to evaluate functional exercise capacity.
Evaluation of upper extremity capacityFirst day and second dayThe six-minute peg board and ring test will be used to assess upper extremity exercise capacity.

Countries

Turkey (Türkiye)

Contacts

Primary ContactBaşak KAVALCI KOL, PhD
basak.kavalci@ahievran.edu.tr+903862802317

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026